Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

The 5th Subcommittee on Microbiome

Press Release

Date and Time: May 12, 2021  from 2pm to 3:40pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

Agenda
  1. Lecture on Microbiome Research and Discussion
    • Current Status and Future Prospects of Live Biotherapeutic Products (LBPs) Attracting Attention As New Therapeutic Modalities
        NAKAMURA Mitsuaki, Senior Director, Bio Palette Co., Ltd. (Lecture and Discussion)
        TAMIYA Taiga, Research and Development Manager, Bio Palette Co., Ltd. (Discussion)
  2. Prewriting the Assigned Parts to Members
  3. Others
List of Handouts
  • Document 1  Lecture Material by Bio Palette Co., Ltd.
  • Document 2  Draft Report on Microbiome (Manufacturing Quality; Chapter 2 & 4)
  • Document 3  Draft Report (Non-clinical Trials)
  • Document 4  Draft Report (Integrated Version)
  • Ref.1  Genetical Recombination